Semax: Dosage, Protocol, and Research Guide
Synthetic analog of ACTH with nootropic and neuroprotective properties
Mechanism
Analog of ACTH(4-10) that increases BDNF levels, modulates monoamine systems (dopamine, serotonin), and provides neuroprotection through reduced oxidative stress and enhanced neuroplasticity.
Protocol at a glance
| Starting dose | 200mcg |
|---|---|
| Maintenance dose | 200-600mcg |
| Maximum dose | 1000mcg |
| Frequency | 1-2 times daily |
| Typical duration | 4-8 weeks cycles |
| Route | Intranasal or subcutaneous |
| Injection site | Abdomen if injected |
| Timing | Morning and early afternoon |
Side effects
- Mild headache
- Nasal irritation (intranasal)
- Possible anxiety at high doses
Contraindications
- Pregnancy
- Acute psychosis
Protocol notes
- Enhances cognitive function and memory
- Increases BDNF levels
- Neuroprotective properties
- May improve mood and reduce anxiety
- Commonly used as nasal spray
Frequently asked questions
What is Semax and how does it work?
Semax is a synthetic analog of ACTH(4-10), a naturally occurring peptide fragment. Unlike full ACTH, Semax delivers neuroprotective and cognitive-enhancing effects without hormonal side effects. Its primary mechanism involves increasing BDNF (brain-derived neurotrophic factor) levels in the hippocampus and other brain regions, supporting neuroplasticity—the brain's ability to form new neural connections. Semax also modulates monoamine systems, particularly dopamine and serotonin, which influence cognition, mood, and motivation. This combination of BDNF elevation and monoamine regulation, coupled with oxidative stress reduction, creates multifaceted neuroprotective and cognitive-enhancing effects.
What is the recommended dosing protocol for Semax?
Semax dosing follows a structured protocol. The starting dose is 200 mcg, taken once daily or split between two administrations. Maintenance dosing ranges from 200-600 mcg daily, with maximum doses reaching 1000 mcg. Administration frequency is 1-2 times daily, with timing preferably in the morning and early afternoon to avoid sleep disruption. Standard usage cycles last 4-8 weeks, after which a break is recommended to allow neurological adaptation and prevent tolerance. Dosing adjustments should be made gradually and under healthcare provider guidance.
What are the side effects of Semax?
Semax is generally well-tolerated, with side effects remaining mild in most cases. Intranasal administration may cause nasal irritation, while some users report mild headaches, especially at higher doses. Anxiety has been documented in some cases, particularly at elevated doses, though this is relatively uncommon. These side effects are typically transient and resolve with dose reduction or discontinuation. Semax is contraindicated in pregnancy and acute psychosis. Any concerns about side effects should be discussed with a healthcare provider.
How is Semax administered?
Semax can be administered via intranasal spray or subcutaneous injection. The intranasal method is the most commonly used approach due to its convenience and non-invasive nature. When administered via injection, the abdomen is the standard injection site. Morning and early afternoon administration is recommended to align with circadian rhythms and optimize cognitive benefits while minimizing sleep interference. Both routes deliver effective results, but intranasal administration is preferred for most users seeking cognitive enhancement.
What cognitive benefits should I expect from Semax?
Semax is primarily used to enhance memory, learning, and mental clarity through its BDNF-elevating mechanism. Users typically report improvements in focus, information processing, and cognitive performance in demanding situations. The neuroprotective properties provide structural brain support, while monoamine modulation contributes to enhanced motivation and emotional resilience. The elevation of BDNF and trkB expression in the hippocampus—documented in peer-reviewed research (PMID 16996037)—creates a biological foundation for these cognitive gains. Effects are generally noticed within days to weeks of consistent use, with benefits developing over a 4-8 week cycle.
Is Semax legal and FDA-approved?
Semax is not FDA-approved for human use and is classified for research purposes only in most jurisdictions. Its legal status varies by country and region, and individuals should verify local regulations before obtaining it. For research purposes only—not FDA-approved for human use. Consult a licensed physician before use. The compound is available through research suppliers and peptide vendors but remains outside standard pharmaceutical approval pathways. Users should be aware of their local laws and source peptides only from reputable suppliers.
How long before I notice results from Semax?
The onset of Semax effects varies by individual and depends on baseline neurological status and sensitivity. Some users report cognitive improvements within days, while others require weeks of consistent use to notice measurable changes. Peak benefits are typically achieved during a 4-8 week cycle, as the nervous system adapts to BDNF elevation and monoamine modulation. Morning and early afternoon timing supports optimal neurological response. Consistent dosing is important, as neuroplasticity and BDNF-driven neural remodeling represent processes that require time.
Who should not use Semax?
Semax is contraindicated in pregnancy and acute psychosis, as safety has not been established in these populations. Individuals with a personal or family history of psychotic disorders should consult a healthcare provider before use, as monoamine modulation could theoretically complicate psychiatric symptoms. Because Semax is not FDA-approved for human use and remains a research compound, it should only be used under the guidance of a licensed physician who can assess individual health status, contraindications, and potential interactions with existing medications.
More Cognitive & Nootropic peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.